![](/img/cover-not-exists.png)
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Hegewisch-Becker, Susanna, Graeven, Ullrich, Lerchenmüller, Christian A, Killing, Birgitta, Depenbusch, Reinhard, Steffens, Claus-Christoph, Al-Batran, Salah-Eddin, Lange, Thoralf, Dietrich, Georg, StLanguage:
english
Journal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(15)00042-X
Date:
September, 2015
File:
PDF, 935 KB
english, 2015